Lipella Pharmaceuticals
LIPO
#10266
Rank
HK$26.82 M
Marketcap
HK$22.19
Share price
-0.70%
Change (1 day)
-63.44%
Change (1 year)

P/S ratio for Lipella Pharmaceuticals (LIPO)

P/S ratio as of January 2025 (TTM): 6.48

According to Lipella Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.35. At the end of 2024 the company had a P/S ratio of 7.50.

P/S ratio history for Lipella Pharmaceuticals from 2022 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.50-29.84%
202310.7-89.05%
202297.6